Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study ‘PolAZA’

Krzysztof Mądrya Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, PolandCorrespondence[email protected]

Karol Lisa Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

Andrzej Tukiendorfb Department of Public Health, Wrocław Medical University, Wrocław, Poland

Paweł Szwedykc Department of Hematology, Voivodal Specialist Hospital, Kraków, Poland

Katarzyna Kapelko-Słowikd Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, University Hospital, Wrocław, Poland

Edyta Subocze Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland

Aleksandra Gołosf Department of Hematology, Institute of Hematology and Blood Transfusion, Warsaw, Poland

Wioletta Makowskaf Department of Hematology, Institute of Hematology and Blood Transfusion, Warsaw, Poland

Anna Masternakg Department of Hematology and Hematooncology, District Specialist Hospital, Opole, Poland

Anna Kopińskah Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland

Magdalena Czemerskai Department of Hematology, Medical University of Łódź, Łódź, Poland

Sara Zawadzka-Leskaa Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

Patrycja Rusickaa Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

Joanna Drozd-Sokołowskaa Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

https://orcid.org/0000-0002-4562-6264

Elżbieta Wiaterj Department of Hematology, District Hospital in Toruń, Toruń, Poland

Jadwiga Hołojdak Department of Hematology, District Specialist Hospital in Legnica, Legnica, Poland

Bartłomiej Pogłódekl Department of Hematooncology, Specialist Hospital, Brzozów, Poland

Piotr Centkowskim Department of Hematology, District Specialist Hospital in Biała Podlaska, Biała Podlaska, Poland

Anna Waszczuk-Gajdaa Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

https://orcid.org/0000-0001-5626-1750

Rafał Machowicza Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

Janusz Hałkae Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland

Tomasz Czerwn Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Warszawa, Poland

Grzegorz Basaka Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

https://orcid.org/0000-0003-3858-8180

Jadwiga Dwilewicz-Trojaczeka Department of Hematology, Oncology and Internal Diseases, Medical University, Warsaw, Poland

https://orcid.org/0000-0002-8572-0335

show all

Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study ‘PolAZA’

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients – results of the PALG study ‘PolAZA’

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date